Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways
International Journal of Molecular Sciences · 27.12.2024 · 26 (1) · 143
DOI: 10.3390/ijms26010143 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.12.2024. Verfasst von Chenxi Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Extracellular Traps, Tetradecanoylphorbol Acetate, Uric Acid, Neutrophils. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Fund of Zhejiang Chinese Medical.
Abstract (Originalsprache)
Neutrophil extracellular traps (NETs) formation is a key process in inflammatory diseases like gout, but the underlying molecular mechanisms remain incompletely understood. This study aimed to establish a model to examine the formation of NETs induced by monosodium urate (MSU) and phorbol 12-myristate 13-acetate (PMA) and to elucidate their molecular pathways. Laser confocal microscopy was used to visualize NET formation, while flow cytometry was employed to detect reactive oxygen species (ROS) production. The microstructure of neutrophils was observed by transmission electron microscopy, and the expression of key proteins was determined by Western blotting. Additionally, the effect of various inhibitors targeting the MAPK signaling pathway on NET formation was evaluated. They include the Ras inhibitor Salirasib, Raf inhibitor Vemurafenib, ERK inhibitor PD98059, and p38 MAPK inhibitor SB203580, as well as NADPH oxidase inhibitor DPI and neutrophil elastase inhibitor Alvelestat. The results showed that MSU and PMA triggered significant NET formation, which was accompanied by increased ROS levels, lactate dehydrogenase release, dsDNA, and IL-8. Notably, selective MAPK pathway inhibitors and DPI and Alvelestat, except for SB203580, effectively down-regulated these indicators. These data indicated that the activation of a signaling pathway involving Ras-Raf-ERK, which is dependent on ROS, is crucial for the induction of NET formation by MSU and PMA. Given the involvement of NETs in multiple pathologies, our findings could potentially serve as molecular targets for the intervention and treatment of crystal-related diseases, especially for gout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
ORCID-Profile: Daozong Xia
Förderung
- National Natural Science Foundation of China
- Scientific Research Fund of Zhejiang Chinese Medical
Zitieren
APA
Wu, C., Xu, X., Shi, Y., Li, F., Zhang, X., Huang, Y., & Xia, D. (2024). Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways. International Journal of Molecular Sciences, 26(1), 143. https://doi.org/10.3390/ijms26010143
Vancouver
Wu C, Xu X, Shi Y, Li F, Zhang X, Huang Y, et al. Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways. International Journal of Molecular Sciences. 2024;26(1):143. doi:10.3390/ijms26010143
BibTeX
@article{Wu2024,
author = {Wu, Chenxi and Xu, Xinru and Shi, Yueyue and Li, Fenfen and Zhang, Xiaoxi and Huang, Yan and Xia, Daozong},
title = {Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {26},
number = {1},
pages = {143},
doi = {10.3390/ijms26010143}
}
EUVIMED